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Abstract
"The Estrogen elixir: A history of hormone replacement therapy in America" by Elizabeth Siegel
Watkins is a thoroughly documented cautionary tale of the information and advice offered to
women in the perimenopausal period of their life, and the consequences of exposure to sexual
hormones on their health and wellbeing.
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Book review
According to Webster's dictionary, an elixir is a substance
sought by alchemists for converting base metals into gold.
Like so many other Elixirs peddled over the centuries,
there are no such things... despite the eagerness of many
to own or benefit from them. The uselessness of elixirs
could have suggested a priori the needless pursuit of read-
ing The Estrogen Elixir: A History of Hormone Replacement
Therapy in America, a book by Elizabeth Siegel Watkins, an
academic historian who takes 351 pages to tell us the
who, the when and the why of this attempt to sell this
"new" elixir to millions of women reaching the age at
which they approach, go through and pass menopause.
The subject is of great public interest because it extends
beyond the specifics of the painful process of (mis)repre-
senting medical evidence to what it says about a society
that considers itself literate, affluent and socially aware.
Professor Siegel Watkins presents a detailed account of the
historical record of the subject. The action takes place in a
very peculiar society, in a well defined environment, dur-
ing most of the second half of the XXth century. The place
is, of course, the United States of America. A close to cyn-
ical rekindling of the argument could be summarized as
follows: first, it was necessary to raise the consciousness of
people (women, in this case) who may not have noticed
until the mid XXth century a need to resolve a non-life
threatening problem such as the inconveniences of men-
opause; second, to propose a "solution" (in this case, an
elixir to neutralize the bad sides of menopause) and "cre-
ate" a market for its commercialization; and finally, to
offer to "those in need" (in this case, women in their 40s
and older) who could afford to pay for an elixir, all the
medical and social justifications to preserve a certainty of
safety, or at least, the idea of the harmlessness of this par-
ticular elixir. The medical-social issues dealt with in the
book cover the last six decades.
It may not be entirely fair to place the protagonists of this
book in the two traditional camps of good and evil. Not-
withstanding, given the capitalistic socioeconomic model
that our westernized society at large has adopted with
gusto during the last century, it would be justifiable to
identify the drug companies as the perceived evil trying to
"add value to the holdings of their shareholders." Con-
sumers could be the innocent targets of the evil doers.
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However, as in all historical accounts involving humans,
there are the virtuous, the marginally virtuous, the mar-
ginally corrupt and the irretrievably corrupt. This being a
scientifically, socially and medically centered story means
that all of the above mentioned characters fill the places
where scientists, "activists" and doctors operate.
And, of course, life is more complex than any simplistic
caricature. As in all social intercourse, the exchanges of
goods among the parties could be negotiated intelligently
and "creatively" for the benefit of all participants or may,
instead, lead to conflicts that cannot be resolved amica-
bly. Examples of conflicts generated by other widely used
consumer products indicate that the Hormone Replace-
ment Therapy (HRT) story became an angry and mischie-
vous one.
Feminism in its broader sense has influenced how women
prefer or demand to be treated by, among others, their
physicians and by Big Pharma. These influences affected
to a significant extent how the dialogue between women
and industry proceeded. But, in the end, the results of
large epidemiological studies decided who was right
about the benefits of the medicalization of menopause
and which were the perils of the indiscriminate use of
HRT.
As a historian, Professor Siegel Watkins presents a schol-
arly account of the issues and the positions the partici-
pants have assumed and defended in this conflict.
Simultaneously, it is not difficult to define on whose
camp she would like to be counted on. In my opinion,
there is nothing wrong with this "fact of life." After all, the
social context in which we all live requires that scholars
lay down "the facts" and make us, the readers, see the rea-
sons under which the narrative justifies siding with one or
another position. For instance, it is of interest to know
that physicians and scientists at large involved in the dis-
covery of the estrogenic drugs in the 1930s were less inter-
ested in personal gains than their colleagues after World
War II. One may conclude (surprise!) that the profit
motive in public relations became exacerbated in the post-
WWII era.
The author judiciously indicates where the faults lie and
who should be blamed for each position taken. It is better
to face the uncertainty with the eyes well open rather than
to blindly fall into desperation and accept risks that may
become serious as age increases. This historical book
should be read by people who have been actively battling
from one or another side of the story, by women who
sooner or later will have to face the decision to take up
medication (HRT) in order to resolve the few and slight or
the many and severe discomforts of menopause, as well as
by informed innocent bystanders who would like to
become better informed of the background and the latest
developments in this medico-social conflict. In this book
there is something for every one of those readers... and for
some, there is a lot indeed.
The ethical and unethical conduct of some of the afore-
mentioned stakeholders will not spare women the heavy
decision of seeking professional help of whichever persua-
sion. In the end, the decision will necessarily be a nar-
rowly personal one. The knowledge of the pros and cons
should make such a decision a liberating exercise where
there is no one position absolutely right. In some cases,
this could be considered a Faustian pact aimed just at
regaining youth, regardless of its ulterior medical health
costs; in others, it may be just a sound therapeutic deci-
sion to improve unacceptable clinical symptoms. In still
other cases, a combination of both extremes may make
women decide to accept the medication and its risks. In
any of these cases, knowing more will undoubtedly be
advantageous to women who should make decisions with
as much honest knowledge as possible
In several chapters, Professor Siegel Watkins proceeds to
dissect who the targets were to the campaign to make
estrogens and its combinations a "need" not an option.
The author goes on to describe in great detail the strategy
used by manufacturers to convince both doctors and
patients of the benefits of using replacement therapy for a
natural condition that used to be handled, admittedly at
times painfully, without the risks of medication. In some
chapters, the author clearly implies that well-regarded
medical and scientific journals, as well as weekly maga-
zines were somehow coaxed to publish articles or com-
mentary that bent the truth regarding the merits and risks
of HRT. From the 1940s to at least the 1970s such an unbi-
ased peer-review process was ignored by editorial boards.
The dissenters, and fortunately there were some even
among lay publications, were not treated that well by the
HRT advocates, and I'm using this word advisedly ("...I'm
shocked!!!").
An interesting angle is explored by the author when she
asks what has been the attitude of women at large to HRT.
Publications have been available since the 1930s report-
ing that estrogens induced mammary cancer in surrogate
laboratory models of carcinogenesis. Given the details
generously referred to in this book, something (the pur-
suit of increasing shareholders value?) or someone (most
probably, not the estrogen consumers) has chosen either
to ignore or de-emphasize the ominous value of this evi-
dence. This attitude is still well and alive today. For exam-
ple, the compelling evidence collected by NIH-supported
researchers should be taken as a warning about the conse-
quences of lax regulation on the use of synthetic estro-
genic compounds present in either consumables (beef,Publish with BioMed Central    and   every 
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pesticide-tainted vegetables, etc) and plastic utensils that
we come into contact with in our daily activities. As in the
case of HRT, those who recommend restraint in the use of
synthetic hormones to increase our "standard of living,"
have to rely on a few bench-scientists and on socially
enlightened individual in the lay community who would
speak up and concern themselves with popularizing to a
rather large scientifically and socially poorly-educated
audience,  the perils of exposure to these compounds.
So, yes, science and technology eventually correct them-
selves. But, at what costs to the innocent bystander who is
unable to weigh the evidence favoring either side fairly?
Starting in 1975 and following in subsequent years, the
tide turned and estrogens began to show what the risks
were in their indiscriminate use (increased incidence of
endometrial and breast cancers). Thus, the results of the
1930s could have been extrapolated to those in the 1970s
without the unnecessary (mostly anonymous) deaths and
suffering of women who, misguided, took the wrong deci-
sion, subjecting themselves to HRT. The incidence of car-
diovascular diseases also increased among HRT users.
In a society like ours where a culprit is supposed to be
identified a posteriori for all things that go wrong (who lost
China? Vietnam? Iraq?), this story is amenable to being
treated in the same context. And the answer is... there is
plenty of blame to be spread among all levels of a society
that considers that we as consumers are here primarily to
do business, and not to promote and enjoy societal under-
standing. An indication of the existence of this exception-
alism is backed up by statistics buttressing the finding that
American women used estrogenic compounds for meno-
pause-related effects in amounts much higher that those
in Australia and Europe. Ultimately, a lack of social edu-
cation in our affluent society might be the culprit; at the
same time, the massiveness of those institutions involved
is such that we all probably feel individually blameless.
If a criticism can be leveled at this book, it is that of being
rather repetitious in presenting the testimony at hand.
One may infer that in her responsible, scholarly effort,
Professor Siegel Watkins wanted to be as informative and
thorough as possible, thus providing the professional
(and the personal) background and even some of the
extracurricular activities of several of the protagonists.
These, at times annoying, details however, detract much
from the overall effective message of this cautionary tale.
All in all, a comparable repetitious and regrettable tech-
nique has been used by the advocates of the HRT and,
regrettably, with unchallengeable effectiveness. 
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